DermaSensor

DermaSensorDermaSensor
DermaSensor

DermaSensor

AI-powered handheld device for early skin cancer detection, aiding dermatologists.

Website
DR 38ActiveMiami, United States
Rate
Advertise here

About

DermaSensor has developed a handheld, AI-powered device designed to assist dermatologists in the early detection of skin cancer. The device uses advanced imaging and artificial intelligence to analyze skin lesions, providing dermatologists with objective data to support their diagnostic decisions and improve patient outcomes.
Frequently asked

What does DermaSensor do?

DermaSensor has developed a handheld, AI-powered device designed to assist dermatologists in the early detection of skin cancer. The device uses advanced imaging and artificial intelligence to analyze skin lesions, providing dermatologists with objective data to support their diagnostic decisions and improve patient outcomes.

What is DermaSensor's revenue?

StartupHub estimates DermaSensor's annual revenue at $2.3M (range $881K to $3.9M, 28% confidence), based on comparable companies in the sector.

What is DermaSensor's valuation?

StartupHub estimates DermaSensor's effective valuation at $57.9M (range $37.5M to $90.0M, 10% confidence), based on comparable companies in the sector.

How much funding has DermaSensor raised?

DermaSensor has raised a total of $15M in funding. The most recent round on record is Series A.

Where is DermaSensor headquartered?

DermaSensor is headquartered in Miami, United States.

What industry does DermaSensor operate in?

DermaSensor operates in HealthTech, MedTech, AI-Driven Protein Design, Computer Vision, Diagnostic Imaging, Medical Devices.

Comments

No comments yet. Be the first to share your take.